Company GB Sciences, Inc. Other OTC
Equities
GBLX
US3615441090
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
President | 54 | 14-06-09 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 18-08-31 |
Darin Carpenter
PRN | Corporate Officer/Principal | 44 | 19-08-27 |
Liz Bianco
PRN | Corporate Officer/Principal | - | - |
Gary Henrie
SEC | Corporate Secretary | 70 | 21-06-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 54 | 14-06-09 | |
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 406,071,028 | 356,459,769 ( 87.78 %) | 0 | 87.78 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |